(Q45310068)

12 December 2017

title

Evidence for decreased transport of tryptophan hydroxylase in Alzheimer's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

4 November 2022

0 references

W. J. Burke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707735

4 November 2022

D. H. Park

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707735

4 November 2022

H. D. Chung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707735

4 November 2022

G. L. Marshall

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707735

4 November 2022

J. H. Haring

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707735

4 November 2022

T. H. Joh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1707735

4 November 2022

language of work or name

English

0 references

publication date

1 December 1990

1 reference

12 December 2017

24 December 1990

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1707735

full work available at URL

4 November 2022

https://api.elsevier.com/content/article/PII:0006899390903429?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

https://api.elsevier.com/content/article/PII:0006899390903429?httpAccept=text/plain

4 November 2022

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

4 November 2022

1 reference

12 December 2017

volume

537

1 reference

12 December 2017

issue

1-2

1 reference

12 December 2017

page(s)

83-87

1 reference

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease.

12 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Amine oxidase and amine metabolism

4 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Phenylethanolamine N-methyltransferase activity is decreased in Alzheimer's disease brains.

4 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease

4 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Detection of 3,4-dihydroxyphenylglycolaldehyde in human brain by high-performance liquid chromatography

4 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Neurotoxic effects of partially oxidized serotonin: tryptamine-4,5-dione.

4 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Selective loss of central cholinergic neurons in Alzheimer's disease

4 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

4 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of the central nervous system

4 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Transmitter deficits in Alzheimer's disease

4 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease

4 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Defective brain microtubule assembly in Alzheimer's disease

4 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes

4 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Postnatal developmental changes of tryptophan hydroxylase activity in serotonergic cell bodies and terminals of rat brain.

4 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.

4 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Serotoninergic system in dementia of the Alzheimer type. Abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid.

4 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE

4 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons

4 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(90)90342-9

4 November 2022

Identifiers

1 reference

12 December 2017

1 reference